Suppr超能文献

成人 2 型糖尿病患者体重管理的饮食方案:已发表荟萃分析的伞状评价和糖尿病缓解饮食试验的系统评价

Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission.

机构信息

Human Nutrition, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.

出版信息

Diabetologia. 2022 Jan;65(1):14-36. doi: 10.1007/s00125-021-05577-2. Epub 2021 Nov 17.

Abstract

AIMS/HYPOTHESIS: Weight reduction is fundamental for type 2 diabetes management and remission, but uncertainty exists over which diet type is best to achieve and maintain weight loss. We evaluated dietary approaches for weight loss, and remission, in people with type 2 diabetes to inform practice and clinical guidelines.

METHODS

First, we conducted a systematic review of published meta-analyses of RCTs of weight-loss diets. We searched MEDLINE (Ovid), PubMed, Web of Science and Cochrane Database of Systematic Reviews, up to 7 May 2021. We synthesised weight loss findings stratified by diet types and assessed meta-analyses quality with A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2. We assessed certainty of pooled results of each meta-analysis using Grading of Recommendations, Assessment, Development and Evaluations (GRADE) (PROSPERO CRD42020169258). Second, we conducted a systematic review of any intervention studies reporting type 2 diabetes remission with weight-loss diets, in MEDLINE (via PubMed), Embase and Cochrane Central Register of Controlled Trials, up to 10 May 2021. Findings were synthesised by diet type and study quality (Cochrane Risk of Bias tool 2.0 and Risk Of Bias In Non-randomised Studies - of Interventions [ROBINS-I]), with GRADE applied (PROSPERO CRD42020208878).

RESULTS

We identified 19 meta-analyses of weight-loss diets, involving 2-23 primary trials (n = 100-1587), published 2013-2021. Twelve were 'critically low' or 'low' AMSTAR 2 quality, with seven 'high' quality. Greatest weight loss was reported with very low energy diets, 1.7-2.1 MJ/day (400-500 kcal) for 8-12 weeks (high-quality meta-analysis, GRADE low), achieving 6.6 kg (95% CI -9.5, -3.7) greater weight loss than low-energy diets (4.2-6.3 MJ/day [1000-1500 kcal]). Formula meal replacements (high quality, GRADE moderate) achieved 2.4 kg (95% CI -3.3, -1.4) greater weight loss over 12-52 weeks. Low-carbohydrate diets were no better for weight loss than higher-carbohydrate/low-fat diets (high quality, GRADE high). High-protein, Mediterranean, high-monounsaturated-fatty-acid, vegetarian and low-glycaemic-index diets all achieved minimal (0.3-2 kg) or no difference from control diets (low to critically low quality, GRADE very low/moderate). For type 2 diabetes remission, of 373 records, 16 met inclusion criteria. Remissions at 1 year were reported for a median 54% of participants in RCTs including initial low-energy total diet replacement (low-risk-of-bias study, GRADE high), and 11% and 15% for meal replacements and Mediterranean diets, respectively (some concerns for risk of bias in studies, GRADE moderate/low). For ketogenic/very low-carbohydrate and very low-energy food-based diets, the evidence for remission (20% and 22%, respectively) has serious and critical risk of bias, and GRADE certainty is very low.

CONCLUSIONS/INTERPRETATION: Published meta-analyses of hypocaloric diets for weight management in people with type 2 diabetes do not support any particular macronutrient profile or style over others. Very low energy diets and formula meal replacement appear the most effective approaches, generally providing less energy than self-administered food-based diets. Programmes including a hypocaloric formula 'total diet replacement' induction phase were most effective for type 2 diabetes remission. Most of the evidence is restricted to 1 year or less. Well-conducted research is needed to assess longer-term impacts on weight, glycaemic control, clinical outcomes and diabetes complications.

摘要

目的/假设:减轻体重是 2 型糖尿病管理和缓解的基础,但对于哪种饮食类型最适合减肥和维持减肥效果仍存在不确定性。我们评估了 2 型糖尿病患者减肥和缓解的饮食方法,为实践和临床指南提供信息。

方法

首先,我们对已发表的关于减肥饮食的随机对照试验荟萃分析进行了系统回顾。我们在 2021 年 5 月 7 日前检索了 MEDLINE(Ovid)、PubMed、Web of Science 和 Cochrane 系统评价数据库。我们根据饮食类型对减肥结果进行了综合分析,并使用 A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2 评估了荟萃分析的质量。我们使用 Grading of Recommendations, Assessment, Development and Evaluations (GRADE)(PROSPERO CRD42020169258)评估了每项荟萃分析结果的综合结果的确定性。其次,我们对报告了减肥饮食对 2 型糖尿病缓解的任何干预研究进行了系统回顾,检索范围包括 MEDLINE(通过 PubMed)、Embase 和 Cochrane 对照试验中心注册库,截至 2021 年 5 月 10 日。根据饮食类型和研究质量(Cochrane 风险偏倚工具 2.0 和非随机干预研究的风险偏倚 [ROBINS-I])对研究结果进行了综合分析,并应用了 GRADE(PROSPERO CRD42020208878)。

结果

我们确定了 19 项减肥饮食的荟萃分析,涉及 2-23 项初级试验(n=100-1587),发表于 2013-2021 年。其中 12 项为“严重低”或“低”AMSTAR 2 质量,7 项为“高”质量。极低能量饮食(每天 1.7-2.1MJ,即 400-500 卡路里)8-12 周的减肥效果最大,比低能量饮食(每天 4.2-6.3MJ,即 1000-1500 卡路里)多减轻 6.6 公斤(95%CI -9.5,-3.7),质量较高(GRADE 低)。配方代餐(高质量,GRADE 中等)在 12-52 周内比 12-52 周内多减轻 2.4 公斤(95%CI -3.3,-1.4)。低碳水化合物饮食与高碳水化合物/低脂肪饮食相比,减肥效果无差异(高质量,GRADE 高)。高蛋白、地中海、高单不饱和脂肪酸、素食和低血糖指数饮食与对照饮食相比,减肥效果均较小(0.3-2 公斤)或无差异(低至严重低质量,GRADE 非常低/中等)。关于 2 型糖尿病缓解,373 条记录中,有 16 条符合纳入标准。在包括初始低能量总饮食替代的 RCT 中,1 年内的缓解率报告为中位数 54%的参与者(低风险偏倚研究,GRADE 高),代餐和地中海饮食的缓解率分别为 11%和 15%(研究中存在一定的偏倚风险,GRADE 中等/低)。对于生酮/极低碳水化合物和极低能量基于食物的饮食,缓解的证据(分别为 20%和 22%)存在严重和关键的偏倚风险,GRADE 确定性非常低。

结论/解释:已发表的关于 2 型糖尿病患者体重管理的低热量饮食荟萃分析不支持任何特定的宏量营养素构成或风格优于其他。极低能量饮食和配方代餐似乎是最有效的方法,通常比自我管理的基于食物的饮食提供更少的能量。包括低热量配方“总饮食替代”诱导期的方案对 2 型糖尿病缓解最有效。大多数证据仅限于 1 年或更短时间。需要进行良好的研究来评估对体重、血糖控制、临床结局和糖尿病并发症的长期影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ee/8660762/b3442664e18c/125_2021_5577_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验